Ohio State Univ. Discusses How Technology Can Detect Hemolysis at the POC


NBC4i-News

In the emergency department, making decisions quickly is of critical importance. However, up to 18.1%1,2 of blood samples tested in the ED are hemolyzed. Ohio State University, Wexner Medical Center, is among the first in the country to utilize a new innovation that detects hemolysis in just 45 seconds3, helping their team ensure patients receive the best possible care.

Implementing Groundbreaking Testing

Dr. Heather Stieglitz, Co-Director of Clinical Chemistry and Toxicology at OSU’s Wexner Medical Center, has long been aware of hemolysis as a potential issue with blood samples. Now, the medical center is utilizing groundbreaking blood gas testing that detects hemolysis at the point of care, for the first time ever. Hemolysis, which can impact the accuracy of potassium results, used to require up to an hour to detect. Now, by eliminating the need to send samples to the lab for hemolysis detection, patient management decisions can be made more quickly and accurately, which is especially important in high-pressure, acute care settings, like OSU’s Emergency Department.

I’m very lucky to work at Ohio State, one of the first places in the country to use this type of blood gas analyzer”

- Dr. Robert Cooper, Clinical Associate Professor of Emergency Medicine at Ohio State University

Robert Cooper, MD, Clinical Associate Professor of Emergency Medicine at OSU, notes an extremely positive difference in the standard of care, since implementing blood gas testing with hemolysis detection at the point of care.

“Rather than having to think ... ‘I trust that this potassium is truly high, and we didn’t hemolyze the sample,’ now you have that accurate information, and you can take a deep breath and say, ‘Okay, now I know what to do,” concluded Dr. Cooper.

Learn more by watching the full NBC4 segment.

  1. Lippi G, Salvagno GL, Favaloro EJ, Guidi GC. Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement. Clin Chem Lab Med. 2009;47(5):616–618. doi:10.1515/CCLM.2009.132.
  2. Nichols JH, Apple FS. Prevalence of hemolyzed results in acute care settings. J Appl Lab Med. 2023;8:431-434. doi:10.1093/jalm/jfac141
  3. Werfen. GEM Premier 7000 with iQM3 Operators Manual. P/N 00000026407. Rev 00. Aug 2023.

G7K NBC4i CB WW Rev00 5.25

Watch the NBC4i news story on detecting blood test errors faster with new technology.

yield

Please be advised that you are now leaving the Werfen Website. Links are provided as a convenience and for informational purposes only. Werfen bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.

https://resources.werfen.com https://info.werfen.com,https://autoimmunity.werfen.com,https://8318686.hs-sites.com https://hemolysisdetection.werfen.com/ https://hemolysisdetection.werfen.com, https://70series.werfen.com http://werfenacademy.com/ https://www.werfen.com http://8318686.fs1.hubspotusercontent-na1.net/ http://share.hsforms.com/